Ecallantide for the Treatment of Hereditary Angiodema in Adults
Hereditary angioedema (HAE) is a clinical disorder characterized by a deficiency of C1 esterase inhibitor (C1-INH). HAE has traditionally been divided into two subtypes. Unique among the inherited deficiencies of the complement system, HAE Types I and II are inherited as an autosomal dominant disord...
Main Authors: | Michael Lunn, Erin Banta |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-01-01
|
Series: | Clinical Medicine Insights: Cardiology |
Online Access: | https://doi.org/10.4137/CMC.S4434 |
Similar Items
-
Ecallantide for the Treatment of Hereditary Angiodema in Adults
by: Michael Lunn, et al.
Published: (2011-05-01) -
Management of acute attacks of hereditary angioedema: role of ecallantide
by: Duffey H, et al.
Published: (2015-04-01) -
Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
by: Farkas H, et al.
Published: (2011-05-01) -
Angiodema due to oral acitretin and isotretinoin Angioedema por acitretina e isotretinoína oral
by: Roberto Rheingantz da Cunha Filho, et al.
Published: (2011-08-01) -
Urticária e angiodema associados a fator estimulador das colônias de granulócitos e macrófagos recombinante humano (rhuGM- CSF) em portador de melanoma metastático Urticaria and angiodema following subcutaneous injection of recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) in a patient with metastatic melanoma
by: Mario Geller, et al.
Published: (2005-12-01)